Answers are grounded in this paper and cite their sources.
Retrospective audit demonstrates high diagnostic yield for alpha-gal syndrome in patients with gastrointestinal symptoms, suggesting underrecognition.
Background Alpha‐gal syndrome (AGS), an IgE‐mediated allergy to galactose‐α‐1,3‐galactose acquired via tick bites, often presents with a delayed gastrointestinal (GI) phenotype without anaphylaxis. We evaluated a local diagnostic guideline in a Far North Queensland gastroenterology outpatient clinic. Methods A retrospective quality assurance audit at Cairns Hospital identified serum‐specific IgE (ssIgE) requests to alpha‐gal 12 months before and 6 months after guideline implementation (12 March 2025). ImmunoCAP ssIgE ≥ 0.1 kU/L was positive. Results Of 19 patients tested, 5 (26%) were sensitized. All had GI‐predominant symptoms—most commonly diarrhea (58%) and abdominal pain (53%)—with no anaphylaxis or respiratory features, and negative preliminary investigations including endoscopy. All three patients completing meat avoidance trials had symptom resolution. Diagnostic yield rose from 2/16 (12.5%) to 3/3 (100%) post‐guideline, though testing was driven almost exclusively by a single clinician. Conclusion The GI phenotype of AGS is present and likely underrecognized in this tick‐endemic region. Targeted ssIgE testing after careful clinical assessment yields high diagnostic value, supporting consideration of AGS in unexplained GI symptoms and extending the recognized distribution of the condition.
No takes yet. Share an insight, caveat, or question.
Bitzer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: